Coldstream Capital Management Inc. Has $554,000 Stock Position in CVS Health Co. (NYSE:CVS)

Coldstream Capital Management Inc. decreased its stake in shares of CVS Health Co. (NYSE:CVS - Free Report) by 29.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 12,352 shares of the pharmacy operator's stock after selling 5,048 shares during the period. Coldstream Capital Management Inc.'s holdings in CVS Health were worth $554,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of CVS. Principal Financial Group Inc. raised its holdings in shares of CVS Health by 4.8% during the third quarter. Principal Financial Group Inc. now owns 1,434,476 shares of the pharmacy operator's stock valued at $90,200,000 after acquiring an additional 66,244 shares during the period. Hall Laurie J Trustee increased its stake in shares of CVS Health by 25,484.4% during the 4th quarter. Hall Laurie J Trustee now owns 11,513 shares of the pharmacy operator's stock worth $517,000 after purchasing an additional 11,468 shares during the last quarter. B&D White Capital Company LLC bought a new position in CVS Health during the fourth quarter valued at about $417,000. Watts Gwilliam & Co. LLC lifted its holdings in CVS Health by 9.8% in the 4th quarter. Watts Gwilliam & Co. LLC now owns 7,302 shares of the pharmacy operator's stock worth $334,000 after purchasing an additional 650 shares during the last quarter. Finally, Seizert Capital Partners LLC grew its stake in CVS Health by 22.8% in the 4th quarter. Seizert Capital Partners LLC now owns 569,527 shares of the pharmacy operator's stock valued at $25,566,000 after buying an additional 105,708 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the stock. UBS Group upped their target price on CVS Health from $67.00 to $71.00 and gave the company a "neutral" rating in a research note on Friday. Truist Financial lifted their target price on shares of CVS Health from $76.00 to $82.00 and gave the company a "buy" rating in a research report on Friday, April 11th. Mizuho raised their price target on shares of CVS Health from $70.00 to $76.00 and gave the stock an "outperform" rating in a research note on Wednesday, April 9th. Leerink Partnrs upgraded CVS Health from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, February 12th. Finally, Wolfe Research boosted their price target on CVS Health from 67.00 to 70.00 and gave the company an "overweight" rating in a research note on Tuesday, February 11th. Four analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $72.69.

Insider Activity

In related news, Director Michael F. Mahoney bought 30,000 shares of CVS Health stock in a transaction that occurred on Tuesday, February 18th. The stock was acquired at an average price of $66.70 per share, with a total value of $2,001,000.00. Following the acquisition, the director now owns 39,356 shares of the company's stock, valued at approximately $2,625,045.20. This represents a 320.65 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP James David Clark sold 7,513 shares of the firm's stock in a transaction that occurred on Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total transaction of $498,487.55. Following the sale, the senior vice president now owns 8,394 shares of the company's stock, valued at $556,941.90. This trade represents a 47.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.22% of the company's stock.

CVS Health Trading Down 2.8 %

NYSE:CVS traded down $1.96 during mid-day trading on Friday, hitting $67.49. The company had a trading volume of 14,303,584 shares, compared to its average volume of 11,558,645. The firm has a market cap of $85.09 billion, a P/E ratio of 18.44, a P/E/G ratio of 0.98 and a beta of 0.57. The business's fifty day moving average is $66.72 and its two-hundred day moving average is $58.87. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.60 and a current ratio of 0.81. CVS Health Co. has a fifty-two week low of $43.56 and a fifty-two week high of $72.51.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, beating the consensus estimate of $1.62 by $0.63. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. The business had revenue of $94.59 billion for the quarter, compared to analysts' expectations of $93.07 billion. During the same period in the previous year, the firm posted $1.31 EPS. The firm's revenue was up 7.0% compared to the same quarter last year. As a group, research analysts expect that CVS Health Co. will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, May 1st. Shareholders of record on Tuesday, April 22nd were given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 3.94%. The ex-dividend date was Tuesday, April 22nd. CVS Health's dividend payout ratio (DPR) is 72.68%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.